Gilead Sciences’ CBPR Programs support community-led research to address health disparities and improve care for underserved populations across diverse therapeutic areas.
Funder: Gilead Sciences
Due Dates: October 9, 2026: Letter of Interest deadline for CREATE-ACE 2026 (CBPR RFP)
Funding Amounts: Amounts vary by project; funding supports community-based research, but specific award sizes are not published.
Summary: Supports community-based organizations in leading research to address health disparities and improve care for underserved populations.
Key Information: Letter of Interest required before full proposal; eligibility focused on organizations rooted in the target community.
Gilead Sciences’ Community-Based Participatory Research (CBPR) Programs are designed to empower community-based organizations to lead research projects that address health disparities and improve quality of care for underserved populations. The program is drug-agnostic and welcomes proposals across diverse therapeutic areas, including HIV, oncology, and liver diseases. Emphasizing direct community engagement and leadership, the CBPR Programs ensure that research priorities and solutions are shaped by those most closely connected to the populations served.